Regulatory sources checked November 7, 2026. General sponsor guidance, not legal advice or an approval guarantee.
Sponsors looking at Guatemala with a CRO usually have two questions that must not be collapsed into one. The first is whether a device can be investigated in humans. The second is whether a device can be imported and sold. MSPAS / DRCPFA is the authority for both, and the files are different.
Investigational authorization is not registration
A device investigation uses Agreement 206-2021, section 43: device description, manufacturer and performance or safety documentation, manufacturing-quality evidence, relevant laboratory and animal evidence, investigator information, and the trial insurance policy. Ethics approval comes before DRCPFA. The complete-file authority period in section 47 is up to 30 business days, with 15 business days for the applicant to answer a query and 15 business days for a decision after that information arrives. That is not a two-to-four-month, six-to-ten-week, or three-to-nine-month promise, and it is not the ethics calendar.
This page does not publish a Guatemala device class range. Classification for the product in front of you has to be confirmed with MSPAS. A quality-system certificate can be relevant to a dossier. This page does not say a particular quality system is mandatory for every product.
ISO 14155 can inform device study planning. This page does not claim that Agreement 206-2021 expressly adopts it. FDA use of foreign device data under 21 CFR 812.28 is conditional on that rule. It is not a clearance.
Do not use a market forecast, a count of sites, or a description of patients as evidence that a first-in-human study will enroll or that a site is qualified. Those claims are not made here. Site, investigator, and emergency-care readiness are protocol-specific.
The study-specific MSPAS pathway, including Phase I and device-investigation requirements, is on clinical trials in Guatemala.
Commercial registration is the other file
Commercial device registration is a different file: Guatemala MSPAS registration and how to register a medical device in Guatemala. Acuerdo Gubernativo 712-99 and Norma Técnica 37 are a commercial framework, not a study permit.
Useful preparation is still concrete. Identify the product, the intended use, and whether the activity is research or sale. Pull the current MSPAS form and the current technical standard, not a saved copy. List which documents need Spanish, apostille, or a Guatemalan sworn translation. Keep the trial importer and any later commercial titular from being improvised in the same contract. Have local counsel read holder, importer, and transfer language. A contract does not override MSPAS.
The step-by-step commercial checklist, including the F-AS-f-08 caveat, is the Guatemala device-registration article.
Primary sources
- MSPAS Agreement 206-2021 and the published clinical-trial norm
- Current clinical-trial application and registration forms
- Official ethics committee and CRO/SMO lists
Contact bioaccess® to request a Guatemala feasibility assessment. Bring the product description, development stage, preclinical evidence, proposed population, procedures, and follow-up.
Frequently asked questions
Which agency reviews a device study in Guatemala?
MSPAS through DRCPFA, after an authorized ethics committee. Do not file the Guatemala study with a foreign regulator.
Can I use a commercial registration to ship investigational units?
No. Investigational supply waits on the ethics and DRCPFA documentation section 103.1 describes. Commercial registration is a separate authorization to sell.
Does this page promise a review time or a network of sites?
No. It separates the two files and points to the current forms. Readiness is established for the protocol, not assumed from a country article.